Sort
46,585 grants matching “heart failure”
High-throughput nanoMEA-based Proarrhythmia Assay
$748,435Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2018 · HL
Exercise Hyperemia in Humans
$748,395Michael J Joyner · Mayo Clinic Rochester · R01 · FY2016 · HL
Defining Genetic Architecture and Pathways of DCM
$748,350Jonathan G Seidman · Harvard Medical School · R01 · FY2023 · HL
CV Benefits and Safety of Glucose-Lowering Therapies in Adults with Diabetes
$748,336Patrick J O'Connor · Healthpartners Institute · R01 · FY2016 · HL
Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study
$748,233James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2006 · HL
Coagulation Control To Protect Gaitko Lung and Liver Xenografts
$748,206Richard N Pierson · University Of Pittsburgh At Pittsburgh · U19 · FY2012 · AI
Dynamic Evaluation of Coronary Intervention Renewal: Drug-Eluting Stents
$748,083Sheryl F. Kelsey · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · HL
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy
$748,000Jimmy Deon Toussaint · Theragnostic Technologies, Inc. · R44 · FY2019 · DK
A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy
$748,000Jimmy Deon Toussaint · Theragnostic Technologies, Inc. · R44 · FY2018 · DK
Arrhythmia mapping using electromechanical wave imaging
$747,962Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2024 · HL
A Multicenter Trial of a Shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE - ICD Trial
$747,960Daniel D Matlock · University Of Colorado Denver · R01 · FY2019 · HL
Deacetylase-Dependent Control of Diastolic Dysfunction and HFpEF
$747,930Timothy McKinsey · University Of Colorado Denver · R01 · FY2022 · HL
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
$747,916Neil C Chi · University Of California, San Diego · R01 · FY2024 · HL
Protein Microcharacterization
$747,907Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2012 · ES
Optimal Stent Selection for the Femoropopliteal Artery
$747,890Alexey Kamenskiy · University Of Nebraska Medical Center · R01 · FY2016 · HL
Overdose Risk Management and Compensation in the Era of Naloxone
$747,873Alexander S Bennett · New York University · R01 · FY2020 · DA
High-throughput nanoMEA-based Proarrhythmia Assay
$747,868Nicholas Andrew Geisse · Curi Bio Inc · R44 · FY2019 · HL
Muscle Mass and Strength Cutpoints in Persons at Risk of Mobility Disability
$747,785Shalendar Bhasin · Brigham And Women'S Hospital · U01 · FY2015 · AG
Multimarker Risk Prediction in Cancer Therapy Cardiotoxicity
$747,668Bonnie Ky · University Of Pennsylvania · R01 · FY2015 · HL
Molecular control of cardiac regenerative potential
$747,663Guo Huang · University Of California, San Francisco · R01 · FY2025 · HL
Defining Genetic Architecture and Pathways of DCM
$747,663Jonathan G Seidman · Harvard Medical School · R01 · FY2022 · HL
Project 2 (Bers)
$747,660Donald M Bers · Stanford University · P01 · FY2022 · HL
Project 2 (Bers)
$747,660Donald M Bers · Stanford University · P01 · FY2020 · HL
Project 2 (Bers)
$747,660Donald M Bers · Stanford University · P01 · FY2023 · HL
Project 2 (Bers)
$747,660Donald M Bers · Stanford University · P01 · FY2021 · HL